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Vigorous apoptosis is induced 3-4 hours after activation of CAMP-dependent protein kmase I in the rat myeloid leukemta cell line IPC-81 [J. Cell. 
Physiol. 146 (1991) 73-801. We will report a novel feature of apoptosis in these cells: a selective and temporarily ordered cleavage within the two 
largest 28s ribosomal RNA variable regions (V3 and V13). The cleavage of 28s rRNA coincided with intemucleosomal DNA fragmentation and 
cessation of cellular protein synthesis. The implication of 28s variable regions as targets in apoptosis is a clue to the function of these so far 
apparently supertluous parts of eukaryotic ribosomes. 
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1. INTRODUCTION 
Apoptotic cell death requires active participation 
from the affected cell, which typically shows shrinkage, 
surface blebbing, chromatin condensation and DNA 
fragmentation [2-51. The molecular mechanisms in- 
volved in this physiological form of cell death are 
largely unknown [5]. In the rat myeloid leukemia cell 
line IPC-81 apoptosis can be triggered by activation of 
the CAMP-dependent protein kinase [l]. Cell death can 
be hindered if inhibitors of protein synthesis are given 
within three hours after CAMP-challenge [l]. When 
doing experiments aimed at finding genes that were in- 
duced in this three hour period, we fortuitously ob- 
served that the 28s rRNA became degraded in parallel 
with other indices of apoptosis, like DNA fragmenta- 
tion and typical morphological changes. This novel fea- 
ture of apoptosis may give a function to ribosomal var- 
iable regions and provides a new angle in the search for 
molecular mechanisms initiating cell death. 
2. MATERIALS AND METHODS 
2.1, Cells und experimental set-up 
The rat myeloid leukemia cell line IPC-8 1 was maintained in RPM1 
with 8% horse serum [6]. Addition of 0.2 mM 8-(4-chlorophenylthio)- 
CAMP (or 8-CPT-CAMP) to the medium caused apoptotic cell death 
after a lag-phase of about three hours. The percentage of apoptotic 
cells at various time points after CAMP-challenge was measured by cell 
counting under bright-field microscopy. Sometimes cells were proc- 
essed for electron microscopy, as described [7]. 
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2.2. Preparation nnd unalysis of RNA and DNA 
RNA and DNA were prepared, electrophoresed and blotted as 
previously descrtbed [8,9]. For preparation of RNA, the cell pellets 
were immediately lysed in 25 mM sodium citrate buffer pH 7 contain- 
ing 4 M guamdinium thiocyanate. 0.5% sodium lauroylsarcosme (w/v) 
and 1% 2-mercaptoethanol (v/v). phenol extracted and isopropanol- 
precipitated. All hybridisations of Northern blots were done with 
5’-“P-labelled oligonucleotides complementary to various parts of rat 
28s rRNA [9] (for details, see Fig. 2). 
2.3. Pulse-chase protein labelling 
The cells were washed in methionine-free DMEM and then grown 
for 30 mm. in methionine-free DMEM with 1% horse serum and 
0.2 mM 8-CPT-CAMP. At the indicated time 65 ,Ki/ml [‘5S]methion- 
me was added. After 15 min labelling, the cells were chased with 
DMEM containing 7% horse serum and 1 mM methionine. 15 mm 
thereafter. the cells were lysed and prepared for SDS-PAGE as de- 
scribed [9]. All the media used had been pregassed and prewarmed. 
3. RESULTS AND DISCUSSION 
Within 3-6 hours after a strong CAMP-challenge 
more than 90% of the IPC-81 cells undergo classical 
apoptosis [l] or type 1 cell death as defined by Clarke 
[4] (Figs. 1 and 4). When scrutinising Northern blots 
from IPC-81 cells it was noted that the large ribosomal 
subunit RNA (LSU-rRNA or 28s rRNA) became de- 
graded (Fig. 1). This degradation was in parallel with 
other indices of apoptosis, like DNA fragmentation and 
typical morphological changes (Figs. 1 and 4). The sizes 
of the different fragments were consistent with a double 
cleavage about 0.7 and 1.2 kb from the 5’ end and a 
single cleavage about 1.5 kb from the 3’ end of the 28s 
rRNA (Fig. 3) i.e. at locations corresponding to the 
two major, V3 and V13, of the 18 recognised variable 
regions of the LSU-rRNA [l&12]. Probing with ol- 
igonucleotides complementary to the regions flanking 
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Fig. 1. Size distribution of leukemia cell RNA, DNA and protein synthesis were evaluated at indicated time (on top of each lane, in hours) of 
incubation with 0.2 mM 8-CPT-cAMP. Top legend: A, 0.2 mM 8-CPT-CAMP; C, 3O,~g/ml cycloheximide; D, IO&ml actinomycin D. Left panel: 
total cellular RNA (25 pg pr. lane) viewed in ethidium bromide-stained 1.5% denaturing agarose gel after electrophoresis (negative image). The 
number at the bottom of each lane represent he percentage of morphologically intact cells at each time point. Middle panel: total cellular DNA 
(10 &lane) viewed in ethidium bromide-stained 1.4% agarose gel after electrophoresis. Note that only the part of the gel with non-fragmented 
DNA (on top of each lane) and the part with DNA sizes from about 3 kb down to 0.2 kb are shown. Right panel: protein synthetic activity measured 
by pulse-chase labelling with [j5S]methionine, followed by electrophoretic separation of labelled proteins. 
V3, V4 and V13, established that the double cut was in 
V3 and the single cut in V13 (Fig. 2). To the best of our 
knowledge, this is the first report of intracellular, selec- 
tive cleavage of rRNA variable regions. 
The time course of accumulation of 28s rRNA frag- 
ments indicated that the cut in V13 resulted in a stable 
1.5 kb 3’ fragment and an unstable 3.3 kb 5’ fragment 
(Fig. 3). The latter fragment was subsequently cleaved 
in V3 and rapidly degraded (Figs. 1, 2). The pathway 
initiated by cut in V 13 thus leads to rapid and extensive 
degradation. 28s rRNA initially cut at V3 was more 
stable towards further degradation (Figs. 1, 2). That 
some 28s rRNAs are preferentially cut at V3 and others 
at V13 may be due to pre-existing intraspecies LSU- 
rRNA variable region heterogeneity, already demon- 
strated [13-151. No 1.2 kb fragment corresponding to 
the 5’ part of 28s rRNA cut at the 3’ extreme of V3 
(V3b) was found (Fig. 2). This indicated that such a cut 
was immediately followed by a cut at V3a. or that it 
occurred after the V3a cut. The results shown in lane 4 
and 5 in Fig. 2 limit the 3’ cut in V3 to an approx. 50 
nucleotide segment in the very 3’ part of V3. Interest- 
ingly, the 3’ extreme of this 50 nucleotide segment com- 
prises the only region which is conserved between 
eukaryotic variable regions (nucleotides 1213-l 235) 
PO]. 
18s rRNA appeared intact after nearly all the 28s 
rRNA and the DNA had been fragmented (Fig. 1). This 
was verified using an 18s rRNA specific oligonucleotide 
probe (Fig. 2). Random RNase action appeared there- 
fore not to be an important factor in the apoptotic 
process. Further evidence for this came from an experi- 
ment were IPC-81 cells underwent wo cycles of freeze/ 
thawing (liquid NJ37”C water bath) followed by incu- 
bation at 37°C for up to two hours. Only a slow and 
general degradation was observed (no specific 28s 
rRNA fragments detected), affecting 18s and 28s 
rRNA to similar extents (data not shown). 
The CAMP-induced apoptosis requires protein syn- 
thesis in the 2-3 hour period after CAMP-challenge [l]. 
Also the CAMP-induced 28s rRNA cleavage was 
blocked by an inhibitor of protein synthesis which also 
blocked DNA fragmentation (Fig. l), underscoring that 
28s rRNA fragmentation depended on similar trigger- 
ing factors as did other apoptotic events. The protein 
synthetic activity was assessed every 15 minutes after 
CAMP-challenge by [35S]methionine pulse-labelling. 
Only when the first signs of 28s rRNA degradation 
appeared (after 2.5-3 hours; Fig. 3), did the protein 
synthetic activity start to decline (not shown). Between 
34 hours after CAMP-challenge protein synthesis de- 
creased disproportionally faster than rRNA degrada- 
tion. There was virtually no protein synthesis 4 hours 
after CAMP-challenge (Fig. l), even though ‘/3 of the 
cells appeared morphologically non-apoptotic. This can 
be explained if inactivation of merely one or a few ribo- 
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Fig. 2. Northern blots of fragmented 28s rRNA hybrid&d with oligonucleotides complementary to the ends of 28s rRNA (1 and 8) and the flanking 
regions of variable regions V3 and V13 (2 to 7), as indicated on the 28s rRNA linear map (top). 28s rRNA variable regions (V-regions; sometimes 
called D-regions) are shown in grey, conserved regions are white. The oligonucleotides were complementary to the following nucleotides of rat 
LSU-rRNA [13]: 1, 17-52 (5’288); 2, 298433 (SV3); 3, 11661197 (3V3a); 4, 12141249 (3Y3b); 5, 1265-1296 (5’V4); 6,2700-2735 (YV13); 7, 
3337-3371 (3Y13); 8,46084643 (3’288, within V18). A probe complementary to nucleotide 1387-1418 (3’V4) gave the same hybridization pattern 
as in lane 5 (5’V4). The arrows labelled Al-C2 indicate the various primary fragments arising from the two cuts at V3 (V3a and V3b) and the 
one cut at V13. as illustrated on the bottom of the figure. 
somes per polysome can stop protein synthesis, as 
shown [16]. Another possibility is that translationally 
active ribosomes were targeted preferentially. Although 
cessation of protein synthesis certainly causes cell death, 
other factors (selective protein synthesis in the early 
stage of rRNA affection ?) must have contributed to 
IPC-81 cell apoptosis, since cycloheximide, while effi- 
ciently blocking protein synthesis, induced apoptosis 
slower (within g-16 hours) than did CAMP (Fig. 1; data 
not shown). 
A mechanism for ribosome inactivation involving the 
variable regions is without precedence. Eukaryotic ribo- 
somal toxins (the ricins, Shiga-toxin and a-sarcin) all 
attack the conserved a-sarcin loop known to be essen- 
tial for protein synthesis [ 17,181. Interestingly, these tox- 
ins can also cause cell death with the characteristics of 
apoptosis [ 191. 
The function of ribosomal variable regions is so far 
unknown [10,12,20,21] , in fact they are thought to be 
dispensable for ribosome function [22,23]. They are 
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Fig. 3. Photograph of agarose-electrophoresed total cellular RNA (25 &lane) from IPC-81 cells at indicated time points (on top, in hours) of 
incubation with 8-(4-chlorophenylthio)-CAMP. L = low dose 8-CPT-CAMP (5 PM). H = high dose 8-CPT-CAMP (0.2 mM). The low dose 
8-CPT-CAMP does not induce apoptosis but can activate CAMP-inducible genes (data not shown). Note that fragmentation resulting from V13 
cleavage (3.3 and 1.5 kb) appear earlier than those produced by the V3 cuts (4.1, 3.6 and 0.7 kb). 
characteristic of eukaryotic rRNA, and there is correla- 
tion between the size of the variable regions and the 
complexity of the organism [12,21]. The variable regions 
V3 and V13 account for more than 70% of the total 
enlargement observed from prokaryotic to eukaryotic 
LSU-rRNAs [12]. Noteworthy, the V3 and V13 regions 
have evolved in a tightly concerted fashion during evo- 
lution [24]. The sequence variability is due to a ‘compen- 
satory slippage’ mechanism which causes variation in 
the length of the major loops within a conserved second- 
ary structure [12,21,25]. In some cases variable regions 
are excised during rRNA processing without religation 
of the rRNA, but excision of V3 or V13 has not been 
reported [12]. 
It is tempting to speculate on the function of the 
variable regions V3 and V13 in light of the present 
findings. If these regions are early targets for apoptotic 
regulation, a functional role in development can be ex- 
pected. Variable region heterogeneity might provide dif- 
ferentiated cellular sensitivity towards apoptotic induc- 
tion. Developmental variegation involving variable re- 
gions, possibly controlled by genetic homing regulated 
by developmentally controlled transposases/gene-spe- 
cific endonucleases [26,27], is an attractive model for 
stage-specific regulation of apoptotic sensitivity. Stage- 
specific ribosome populations have been observed in 
Plasmodium [28]. The tight connection between selective 
Fig. 4. Section of an IPC-81 cell in apoptosis (after 4 h of incubation 
with 0.2 mM 8-(4-chlorophenylthio)cAMP) (9000x). Note the chro- 
matin condensation, nuclear fragments and pronounced cellular disin- 
tegration. Mitochondria appeared intact, even at larger magnification 
(not shown). 
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cleavage of LSU-rRNA and the apoptotic process, as 
disclosed in the present study, gives a new angle for 
understanding the rDNA evolutionary paradox [29]. 
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